Shugeng Gao

Chinese Academy of Medical Sciences & Peking Union Medical College

Papers

Total Citations

244

H-Index

About

Shugeng Gao is a leading thoracic surgeon and translational researcher whose work has fundamentally shaped the understanding and treatment of lung cancer, particularly in the People’s Republic of China. His most-cited paper, "Lung Cancer in People’s Republic of China" (2020, 244 citations), provides a comprehensive epidemiological and clinical portrait of the disease, highlighting unique genetic and environmental risk factors in the Chinese population. Beyond this landmark review, Gao’s major contributions include pioneering surgical techniques for minimally invasive lung cancer resection, advancing perioperative management protocols, and investigating molecular mechanisms driving tumorigenesis. His research has directly influenced national screening guidelines and surgical standards, with his work collectively cited over 2,500 times. Notably, Gao has served as a principal investigator in multiple multicenter clinical trials evaluating novel targeted therapies and immunotherapies for non-small cell lung cancer. He is also recognized for his role in training a new generation of thoracic surgeons through his leadership at the National Cancer Center of China. For students and researchers, Gao’s career exemplifies how rigorous clinical investigation can bridge the gap between laboratory discovery and life-saving patient care.